Fmoc-L-tyrosine

Fmoc-L-tyrosine is an Fmoc-protected L-tyrosine amino acid bearing a chiral α-carbon, a phenolic side chain, and a carbamate-protected amine suitable for stepwise peptide assembly. The Fmoc group provides base-labile protection for the N-terminus, while the free phenol enables selective side-chain chemistry without requiring additional protection in many coupling workflows. The molecule contains both an aromatic ring and a phenolic hydroxyl that can participate in hydrogen bonding and can be functionalized through electrophilic aromatic substitution, acylation, or ether formation under controlled conditions. As a protected amino acid building block, it functions as a stereochemically defined intermediate for preparing tyrosine-containing peptides, peptidomimetics, and downstream conjugates.

1. Peptide Synthesis

Fmoc-L-tyrosine is used in peptide synthesis workflows where Fmoc-based N-protection supports iterative N-terminal deprotection and coupling cycles. The chiral L-configuration and the Fmoc carbamate allow reliable incorporation of tyrosine at defined positions, while the free phenolic side chain can be retained for later modification or selectively transformed during synthesis. Phenol reactivity supports orthogonal side-chain derivatization strategies, including conversion to O-alkyl or O-acyl derivatives for controlling solubility and protecting-group compatibility. Downstream tyrosine-containing peptides and peptide fragments prepared from this building block are applicable to biochemical research, assay development, and materials-oriented peptide constructs.

2. Side-Chain Functionalization

Fmoc-L-tyrosine is applied in amino acid derivatization and side-chain functionalization strategies targeting the phenolic hydroxyl of tyrosine. The presence of an unprotected phenol enables controlled O-functional group installation, including etherification for linker introduction, acylation for stability tuning, or further transformation into reactive handles for conjugation chemistry. The Fmoc group provides an orthogonal protection element so that phenol modification can be performed without disturbing the N-protection when compatible conditions are selected. Resulting O-functionalized tyrosine derivatives can serve as intermediates for peptidomimetics, affinity reagents, and chemically defined biomolecule conjugates.

3. Bioconjugation Chemistry

Fmoc-L-tyrosine is suitable for bioconjugation and chemical biology applications where tyrosine side-chain chemistry is used to generate defined attachment points. The phenolic group can participate in coupling or derivatization routes that yield stable linkages for attaching peptides to proteins, polymers, or surfaces, while the Fmoc-protected amine supports preparation of peptide conjugates with controlled N-termini. Stereochemical fidelity at the α-carbon helps maintain structural recognition features when tyrosine residues are embedded in larger constructs. Downstream conjugate libraries and labeled peptide reagents can be assembled from this chiral building block for mechanistic studies, binding assays, and analytical method development.

4. SAR Studies

Fmoc-L-tyrosine is employed in medicinal chemistry and structure-activity relationship studies that require tyrosine-containing analogs with defined stereochemistry and modifiable side-chain properties. The aromatic phenol enables systematic exploration of hydrogen-bonding and aromatic interactions by converting the hydroxyl into ethers, esters, or other substituents to modulate polarity and steric profile. The Fmoc group supports synthesis of analog series through consistent peptide coupling chemistry, enabling parallel construction of peptide-based scaffolds or peptidomimetic fragments. Resulting tyrosine analogs can be used as chemically characterized intermediates for SAR workflows, fragment elaboration, and assay-compatible molecular design.

5. Pharmaceutical Manufacturing

Fmoc-L-tyrosine is applicable to pharmaceutical manufacturing and process chemistry for producing tyrosine-containing peptide intermediates used in active pharmaceutical ingredient synthesis or peptide-based intermediate streams. The base-labile Fmoc protection supports controlled deprotection steps in manufacturing-scale peptide assembly, while the phenolic side chain can be managed through orthogonal protection or selective derivatization to meet downstream coupling and purification requirements. The defined L-stereochemistry and functional group pattern support reproducible incorporation into larger sequences and consistent impurity profiles associated with protected amino acid handling. Industrially, this building block can be incorporated into fine chemical synthesis routes for producing peptide fragments, protected intermediates, and chemically defined materials that feed subsequent purification and conversion steps.

1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

3. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

4. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes